Author: Aditya Pareek | EQMint | Market News
The Indian stock market ended a highly eventful week on a positive note, overcoming phases of volatility, foreign fund outflows, and rupee weakness to post respectable gains. Despite intermittent bouts of profit booking, benchmark indices remained resilient and even touched fresh lifetime highs during the week. Supportive global cues—particularly softer U.S. Treasury yields, renewed expectations of a U.S. Federal Reserve rate cut, and cooling crude oil prices—helped ease inflation concerns and strengthened sentiment in domestic equities.
While sectors such as Pharma, PSU Banks, Media, and IT led the week’s upmove, others including Realty, Consumer Durables, and Oil & Gas lagged behind. The market’s ability to absorb selling pressure and bounce back strongly highlights the underlying confidence among domestic investors, even as FIIs continue to remain net sellers.
Against this backdrop of improved sentiment and technical stability, Sumeet Bagadia, Executive Director at Choice Broking, has recommended three high-conviction stocks to buy on Monday, December 1, 2025: Dr Reddy’s Laboratories, Titan Company, and HCL Technologies.
Market Outlook: Nifty 50 Poised to Head Higher
According to Sumeet Bagadia, the broader market setup remains constructive as long as the Nifty 50 holds above crucial support levels.
Sumeet Bagadia noted that the index is sustaining above 26,200 after hitting a new peak, setting the stage for the next leg of the rally.
“The Indian stock market sentiment is positive as long as Nifty stays above 26,000. The index has built a strong base at 25,800–25,750 and is poised to reach 26,500 soon. If Nifty breaks above 26,500 on a closing basis, we may see it move toward 27,200 in the near term,” he said.
Sumeet Bagadia added that traders should maintain a stock-specific approach, focusing on counters with strong technical structures rather than chasing overextended names.
Three Stocks to Buy on Monday According to Sumeet Bagadia
Sumeet Bagadia has identified three stocks that show strong technical setups and offer favorable risk-reward ratios for the coming week.
1️⃣ Dr Reddy’s Laboratories — Buy at ₹1,258 | Target: ₹1,350 | Stop Loss: ₹1,210
Dr Reddy’s has shown a steady recovery from recent lows and is currently trading between ₹1,258 and ₹1,260. The stock has reclaimed its 20-day and 50-day EMAs, signaling strength after a prolonged consolidation phase.
Why It’s a Buy:
- Price is approaching the 100 & 200-EMA cluster, indicating a potential trend reversal zone.
- Formation of higher lows suggests early accumulation.
- Moderate but stable volumes confirm steady buying interest.
- Strong support at ₹1,240–₹1,250, previously a congestion zone.
Key Levels:
- Resistance: ₹1,300–₹1,350
- Support: ₹1,200–₹1,210
A breakout above ₹1,350 could unlock stronger momentum, making Dr Reddy’s one of the top pharmaceutical picks for the coming week.
2️⃣ Titan Company — Buy at ₹3,907 | Target: ₹4,200 | Stop Loss: ₹3,777
Titan Company continues to trade in a strong bullish structure, comfortably above all major EMAs. The stock has staged an impressive rally from its October lows, with consistently higher highs and higher lows.
Why It’s a Buy:
- Sustaining above ₹3,880–₹3,900 reinforces bullish sentiment.
- Strong support at ₹3,730–₹3,840 backed by rising EMAs.
- Volumes remain healthy, indicating institutional participation.
- After a long consolidation phase, Titan has regained directional momentum.
Key Levels:
- Resistance: ₹4,050–₹4,150
- Target Projection: ₹4,200 based on Fibonacci extensions
A breakout above ₹4,150 could pave the way for an extended rally in the consumer & lifestyle segment.
3️⃣ HCL Technologies — Buy at ₹1,625 | Target: ₹1,750 | Stop Loss: ₹1,570
HCL Tech has shown a decisive trend reversal from its recent bottom near the ₹1,400 region. The stock is in a clear upward trajectory, forming a series of higher highs and higher lows while trading above all major EMAs.
Why It’s a Buy:
- Price comfortably above 20/50/100/200 EMAs with strong momentum.
- 20-EMA rising sharply, serving as dynamic support.
- Healthy volume expansion suggests accumulation on dips.
- Breakout above ₹1,550–₹1,570 zone confirms bullish trend formation.
Key Levels:
- Resistance: ₹1,680–₹1,717
- Support: ₹1,560–₹1,590
A breakout above ₹1,717 could fuel a strong upward move, with the potential to surpass ₹1,750 in the short term.
Sector Trend: Where the Opportunities Lie
While Nifty remains on firm footing, sector rotation continues to play a major role in market behavior.
This week saw leadership from:
- Pharma
- PSU Banks
- IT & Media
Meanwhile, sectors such as Realty, Oil & Gas, and Consumer Durables underperformed, highlighting selective buying and cautious profit-taking.
Bagadia suggests tracking sectors showing early signs of strength and leaning towards stocks that are standing out technically even in a choppy market.
What to Expect on Monday
Given:
- Positive global cues,
- Declining U.S. yields,
- Expectations of a Fed rate cut,
- Steady domestic flows, and
- Nifty’s strong support above 26,000,
analysts believe Monday could witness a firm opening, with stock-specific movements driving the day.
The three recommended stocks—Dr Reddy’s, Titan, and HCL Tech—are expected to show strong reactions and maintain bullish momentum if broader sentiment remains intact.
For more such insights visit EQMint
Disclaimer: This article is based on information available from public sources. It has not been reported by EQMint journalists. EQMint has compiled and presented the content for informational purposes only and does not guarantee its accuracy or completeness. Readers are advised to verify details independently before relying on them.
